A Study of CCX168 in Japanese and Caucasian Healthy Adult Males

NCT05988008 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

Interventions

DRUG: CCX168
DRUG: Placebo

Sponsor

Amgen